Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
G., Mace, K
efficacy goal was not met Claim 300500 mcg per day Published human support No controlled human SubQ study Community support Commonly reported How it should be described Community research amount Claim Start at 300 mcg and increase after four weeks Published human support No Community support Commonly reported How it should be described Anecdotal step-up model Claim 8- or 16-week SubQ cycle Published human support No Community support Commonly reported How it should be described Community timeline only Claim Use beyond 24 weeks Published human support No Community support Scattered reports How it should be described Unsupported by published long-term evidence AOD-9604 is not an FDA-approved drug
It is worth noting that there does appear to be a trial administering BPC 157 (rectally administered) in human participants for the treatment and healing of acute to mild ulcerative colitis (Veljaca et al
If you are serious about using BPC-157 safely and effectively, the right move is to work with professionals who can guide every step of the process
Quality Assurance: Manufactured in compliance with rigorous pharmaceutical standards for safety and efficacy
